Targeting CD52 provides durable depletion of circulating CAR T cells in a patient with BCMA-CAR T-cell–associated parkinsonism. // Blood Immunology & Cellular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S3050597626000400?dgcid=rss_sd_all
Targeting CD52 provides durable depletion of circulating CAR T cells in a patient with BCMA-CAR T-cell–associated parkinsonism. Blood Immunology & Cellular Therapy. https://www.sciencedirect.com/science/article/pii/S3050597626000400?dgcid=rss_sd_all
“Targeting CD52 provides durable depletion of circulating CAR T cells in a patient with BCMA-CAR T-cell–associated parkinsonism.” Blood Immunology & Cellular Therapy.
@article{article38453,
title = {Targeting CD52 provides durable depletion of circulating CAR T cells in a patient with BCMA-CAR T-cell–associated parkinsonism},
journal = {Blood Immunology \& Cellular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S3050597626000400?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez